BALPHARMA — Bal Pharma Balance Sheet
0.000.00%
- IN₹1.65bn
- IN₹3.03bn
- IN₹3.03bn
- 63
- 37
- 25
- 36
Annual balance sheet for Bal Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 56.5 | 74.5 | 90.8 | 211 | 118 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 693 | 778 | 951 | 1,011 | 946 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,641 | 1,846 | 2,282 | 2,341 | 2,349 |
Net Property, Plant And Equipment | 575 | 572 | 622 | 621 | 738 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 2,401 | 2,605 | 3,132 | 3,195 | 3,357 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,525 | 1,656 | 2,093 | 2,030 | 2,195 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,865 | 2,019 | 2,494 | 2,502 | 2,583 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 536 | 586 | 638 | 693 | 774 |
Total Liabilities & Shareholders' Equity | 2,401 | 2,605 | 3,132 | 3,195 | 3,357 |
Total Common Shares Outstanding |